04:43 PM, 30th Jan 2026
Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve This is to inform that a Meeting of the Board of Directors of the Company will be held on Monday February 9 2026 to consider and approve inter alia the Standalone & Consolidated Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2025.